About ESSEX Chemie
ESSEX Chemie AG, based in Lucerne CH, is one of the subsidiaries of the globally active pharmaceutical group Schering-Plough Corporation (USA). Schering-Plough Corporation bears the name ESSEX in German-speaking countries to avoid confusion with Berlin-based Schering AG, with which we share common roots but no longer have any connection.
The core business comprises prescription drugs in the fields of allergy, dermatology, drug substitution, gastroenterology, oncology, cardiology and rheumatology. In addition, Schering-Plough operates a global veterinary business and carries consumer brands in the areas of foot care, sun care and over-the-counter medicines.
Our key products include Aerius®, Caelyx®, Claritine®, Elocom®, Ezetrol®, Inegy®, Intron A®, Nasonex®, PegIntron®, Rebetol®, Remicade®, Subutex®, Temodal®.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Advertisement
